ANAB logo

ANAPTYSBIO INC

ANABNASDAQ
🏆 #1912 by market capEarnings Aug 12US Equity
$57.64▼ $0.23 (−0.40%)
Live
1h▲ 0.5%
24h▼ 0.4%
7d▲ 4.7%
14d▲ 10.5%
30d▼ 17.4%
1y▲ 187.2%
🏦Market Cap
$1.71B
Small Cap
📈Revenue Growth (YoY)
+107.7%
High Growth
📊Gross Margin
—
💵FCF Margin
42.2%
Strong
⚖️P/S Ratio
7.1x
Fair
Otter Score
57
Weak
📊

Analyst Ratings

Price
$57.64
Total
22
Raised
0
Lowered
3
Avg PT
$73.67
H / L
$90 / $50
InstitutionActionRatingDate
Barclays
ReiteratedOverweight2026-05-13
UBS
ReiteratedBuy2026-05-13
Piper Sandler
ReiteratedOverweight2026-05-04
Leerink Partners
ReiteratedOutperform2026-04-28
HC Wainwright & Co.
ReiteratedBuy2026-03-30
Wedbush
ReiteratedOutperform2026-03-12
Truist Securities
ReiteratedHold2026-03-09
Stifel
ReiteratedBuy2026-03-05
Wells Fargo
ReiteratedOverweight2025-11-05
Guggenheim
ReiteratedBuy2025-11-05
JP Morgan
ReiteratedOverweight2025-07-24
BTIG
DowngradedBuy → Neutral2024-12-02
Raymond James
DowngradedOutperform → Market Perform2023-01-06
Credit Suisse
ReiteratedNeutral2020-05-07
SunTrust Robinson Humphrey
ReiteratedHold2020-03-03
H.C. Wainwright
ReiteratedBuy2018-12-20
Cantor Fitzgerald
ReiteratedOverweight2018-08-28
JMP Securities
ReiteratedMarket Outperform2018-08-15
RBC Capital
DowngradedOutperform → Sector Perform2018-04-04
Stifel Nicolaus
ReiteratedBuy2018-03-27
Jefferies
ReiteratedBuy2017-11-09
Baird
ReiteratedOutperform2017-07-11
One row per institution, most recent rating